Lower serum magnesium level is an important risk factor for erythropoiesis-stimulating agents hypo-responsiveness in hemodialysis patients
Abstract Purpose There is an established inverse association between serum magnesium levels and anemia in the general population. However, limited information is available about this association in patients on hemodialysis. This study investigated the relationship between serum magnesium and anemia...
Saved in:
Main Authors: | Hayam Hebah, Shaimaa Abdelmegied, Dina Osman, Lina Khedr |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-02-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-025-00407-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Intravenous Versus Oral Administration of Levocarnitine in Maintenance Hemodialysis Patients: A Randomized Controlled Trial Investigating Therapeutic Approaches to Renal Anemia
by: Sadia Rehman, et al.
Published: (2025-01-01) -
Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients
by: Li Cui, et al.
Published: (2024-12-01) -
Appropriate Use of Inpatient Erythropoiesis Stimulating Agents
by: Chenghao Cui, et al.
Published: (2024-11-01) -
Therapy of resistant hypertension in patients with chronic kidney disease complications of anemia in hemodialysis: a case report
by: Yenry Sumarlim, et al.
Published: (2023-11-01) -
Contribution of vitamin B 6 deficiency to anemia in children on regular hemodialysis
by: Fatma Atia, et al.
Published: (2025-01-01)